Direct to Consumer Series C Investors & VC Firms
27 firms in this list, with a median first check of $500K. 6 of them lead rounds. Generated from verified public data and updated continuously.
Norwest Venture Partners
Menlo ParkSeed–Late Stage$10M – $30M
49 people
Evolution VC Partners
New YorkPre-Seed–Late Stage
2 people
Collaborative Fund
New YorkSeed–Growth$500K – $1M
22 people
mint VC
TokyoPre-Seed–Growth$283K – $20M
16 people
Active Partners
LondonSeed–Growth$250K – $19M
14 people
APOLLO CAPITAL
TokyoSeed–Growth
16 people
Aglae Ventures
ParisPre-Seed–Late Stage$108K – $5.4M
9 people
Unilever Ventures
LondonSeed–Late Stage$540K – $10.8M
15 people
The Craftory
LondonSeed–Late Stage$15M – $150M
22 people
Btomorrow Ventures
LondonSeed–Growth
21 people
Sixth Sense Ventures
MumbaiSeed–Series C$6M – $13M
16 people
Stride Consumer Partners
BostonSeries C–Growth
21 people
Verlinvest
BrusselsSeed–Late Stage
13 people
German Media Pool
BerlinSeed–Late Stage$550K – $5.5M
7 people
Miroma Ventures
LondonSeed–Late Stage$250K – $5M
1 person
AMBERSTONE
San FranciscoSeries A–Late Stage$500K – $10M
5 people
Consumer Ventures
HinsdaleSeries A–Late Stage$500K – $10M
7 people
Altelan
SeattleSeries A–Growth
7 people
Holtzbrinck Ventures
EuropeSeed–Growth
1 person
Legendary Ventures, Llc.
New York CitySeed–Late Stage
6 people
Uncapped
LondonSeries A–Growth$100K – $2M
1 person
Outfund
MilanSeries A–Growth$13K – $650K
1 person
Katjes Greenfood
DüsseldorfSeed–Late Stage
2 people
Clearco
TorontoSeed–Late Stage
3 people
Related lists
Series C Investors & VC Firms (2751)Series C Investors & VC Firms in United States (906)Series C Investors & VC Firms in Global (852)Healthtech Series C Investors & VC Firms (771)SaaS Series C Investors & VC Firms (752)Enterprise Software Series C Investors & VC Firms (748)Fintech Series C Investors & VC Firms (698)AI & Machine Learning Series C Investors & VC Firms (659)Biotech Series C Investors & VC Firms (600)Series C Investors & VC Firms in Europe (600)
Data sourced from public filings and firms' own websites — see our methodology.





















































